HIV in the neonate

Journal of Hospital Infection

Volumn 37, Issue 3, 1997, Pages 181-198

  Gray, J ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; HIV; Neonate; Pregnancy; Transmission; Treatment

Indexed keywords

ANTIVIRUS AGENT; ZIDOVUDINE;

FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEWBORN; NEWBORN INFECTION; PREGNANCY; PROGNOSIS; REVIEW; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0030856893     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(97)90247-4     Document Type: Review

References (115)

1. Kühn L, Stein ZA. Mother-to-infant HIV transmission: timing, risk factors and prevention. Pediatr Perinatal Epidemiol 1995; 9: 1-29.
2. Alger LS, Farley JJ, Robinson BA, Hines SE, Berchin JM, Johnson JP. Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol 1993; 82: 787-796.
3. Connor E, McSherry G. Treatment of HIV infection in infancy. Clin Perinatol 1994; 21: 163-177.
4. Mok J. HIV infection in children. Millions will suffer. Br Med J 1991; 302: 921-923.
5. Scott GB, Hutto C, Makuch RW et al. Survival in children with perinatally acquired human immunodeficiency virus type I infection. N Engl J Med 1989; 321: 1791-1796.
6. Mertens TE, Belsey E, Stoneburner RL, Low Beer D, Sato P, Burton A, Merson MH. Global estimates and epidemiology of HIV-1 infections and AIDS: further heterogeneity in spread and impact. AIDS 1995; 9 (Suppl A): S259-S272.
7. Dinsmoor MJ. HIV infection and pregnancy. Clin Perinatol 1994; 21: 85-93.
8. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe - 1994/96. WHO-EC Collaborating Centre on AIDS, 1996.
9. Unlinked Anonymous Surveys Steering Group. Unlinked Anonymous HIV Prevalence Monitoring Programme England and Wales. Department of Health, December 1996.
10. Tappin DM, Johnstone FD, Smith R, Girdwood RW, Follett EA, Davidson CF. Spread of maternal HIV infection in Scotland from 1990 to 1992. Scot Med J 1995; 40: 12-14.
11. Ades AE, Davison CF, Holland FJ et al. Vertically transmitted HIV infections in the British Isles. Br Med J 1993; 306: 1296-1299.
12. Nair P, Alger L, Hines S, Seiden S, Hebel R, Johnson JP. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acq Immune Def Synd 1992; 6: 298-302.
13. Hira SK, Kamanga J, Bhat J et al. Perinatal transmission of HIV-1 in Zambia. Br Med J 1989; 299: 1250-1252.
14. Ryder RW, Nsa W, Hassig SE et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. New Engl J Med 1989; 320: 1637-1642.
15. St Louis ME, Kamenga M, Brown C et al. Risk for perinatal HIV-1 transmission according to maternal immunological virologic, and placental factors. JAMA 1993; 269: 2853-2859.
16. Johnstone FD, MacCallum L, Brettle R, Inlis JM, Peutherer JF. Does infection with HIV affect the outcome of pregnancy? Br Med J 1988; 296: 467.
17. Minkoff HL, Henderson C, Mendez H et al. Pregnancy outcomes among mothers infected with HIV and uninfected control subjects. Am J Obstet Gynecol 1990; 5: 1598-1605.
18. Selwyn PA, Schoenbaum EE, Davenny K et al. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989; 261: 1289-1294.
19. Anonymous. Risk factors for mother-to-child transmission of HIV-1 European Collaborative Study. Lancet 1992; 339: 1007-1012.
20. Gabiano C, Tovo PA, de Martino M et al. Mother-to-child transmission of HIV-1 Risk of infection and correlates of transmission. Pediatrics 1992; 90: 369-374.
21. Blanche S, Rouzioux C, Moscato MLG et al. (French Collaborative Study). A prospective study of infants born to women seropositive for HIV-1 New Engl J Med 1989; 320: 1643-1648.
22. Hutto C, Parks WP, Lai S et al. A hospital-based prospective study of perinatal infection with HIV-1. J Pediatr 1991; 118: 347-353.
23. Mok JY. Vertical transmission. Baillieres Clin Obstet Gyn 1992; 6: 85-100.
24. Rouzioux C, Costagliola D, Burgard M et al. Timing of mother-to-child HIV-1 transmission depends on maternal status. AIDS 1993; 7 (Suppl): S49-S52.
25. Ruff A, Coberly J, Halsey NA et al. Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlations with maternal factors. J Acq Immunodef Synd 1994; 7: 68-73.
26. Van de Perre P, Hitimana DG, Lepage P. Human immunodeficiency virus antibodies of IgG, IgA and IgM subclasses in milk seropositive mothers. J Pediatr 1988; 113: 1039-1041.
27. Van de Perre P, Lepage P, Homsy J, Dabis F. Mother-to-infant transmission of human immunodeficiency virus by breast milk: Presumed innocent or presumed guilty? Clin Infect Dis 1988; 15: 502-507.
28. Lederman SA. Estimating infant mortality from HIV and other causes in breast-feeding and bottle-feeding populations. Pediatrics 1992; 89: 290-296.
29. Oxtoby MJ. Human immunodeficiency virus and other viruses in human milk: placing the issues in broader perspective. Pediatr Infect Dis J 1988; 7: 825-835.
30. Hira SK, Mangrola UG, Mwale C et al. Apparent vertical transmission of human immunodeficiency virus type 1 by breast feeding in Zambia. J Pediatr 1990; 117: 421-424.
31. Palasanthiran P, Ziegler JB, Stewart GJ et al. Breast feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis 1993; 167: 441-444.
32. Van de Perre P, Simonon A, Msellati P et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. New Engl J Med 1991; 325: 593-598.
33. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breast feeding. Lancet 1992; 340: 585-588.
34. De Martino M, Tovo PA, Tozzi AE et al. HIV-1 transmission through breast-milk: appraisal of risk according to duration of feeding. AIDS 1992; 6: 991-997.
35. De Martino M, Tovo PA. Quantifying the risk of HIV-1 transmission via breast-milk. AIDS 1993; 7: 135.
36. Dunn D, Newell ML. Quantifying the risk of HIV-1 transmission via breast-milk. AIDS 1993; 7: 134.
37. Cohn JA. Recent advances. HIV infection - 1. Br Med J 1997; 314: 487-491.
38. Roques P, Marce D, Courpotin C et al. Correlation between HIV provirus burden and in utero transmission. AIDS 1993; 7 (Suppl. 2): S39-S43.
39. Tovo PA, de Martino M, Gabiano C et al. Mode of delivery and gestational age influence perinatal HIV-1 transmission. Italian Register for HIV Infection in Children. J Acq Imm Def Synd Human Retroviral 1996; 11: 88-94.
40. Bulterys M, Chao A, Dushimimana A et al. Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS 1993; 7: 1639-1645.
41. Hague RA, Mok JYQ, Johnstone FD et al. Maternal factors in HIV transmission. Int J STD AIDS 1993; 4: 142-146.
42. Jackson JB, Kataaha P, Horn DM et al. β2-microglobulin, HIV-1 p24 antibody and acid dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women. AIDS 1993; 7: 1475-1479.
43. Lepage P, Van de Perre P, Msellati P et al. Mother-to-child transmission of HIV-1 and its determinants: A cohort study in Kigali, Rwanda. Am J Epidemiol 1993; 137: 589-599.
44. Scarlatti G, Lombardi V, Plebani A et al. Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children. AIDS 1991; 5: 1173-1178.
45. Tibaldi C, Ziarati N, Salassa B, D'Ambrosio R, Sinicco A. Asymptomatic women at high risk of vertical HIV-1 transmission to their fetuses. Br J Obstet Gynaecol 1993; 100: 334-337.
46. Frenkel LD, Gaur S. Perinatal HIV infection and AIDS. Clin Perinatol 1994; 21: 95-107.
47. Scarlatti G, Leitner T, Hodara V et al. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. AIDS 1993; 7 (Suppl 2): S45-S48.
48. De Martino M, Tovo PA, Galli L et al. HIV-1 infection in perinatally exposed siblings and twins. Arch Dis Child 1991; 66: 1235-1238.
49. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaris infection. AIDS 1995; 9: 721-726.
50. Mandelbrot L, Mayaux MJ, Bongain A et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 1996; 175: 661-667.
51. Clericic M, Sison AV, Berzofsky JA et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 1993; 7: 1427-1433.
52. de Moraes-Pinto MI, Almeida AC, Kenj G et al. Placental transfer and maternally-acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996; 173: 1077-1084.
53. Robertson CA, Mok JYQ, Froebel KS et al. Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of HIV. J Infect Dis 1992; 166: 704-709.
54. Mok JYQ, Hague RA, Yap PL et al. Vertical transmission of Hiv: a prospective study. Arch Dis Child 1989; 64: 1140-1145.
55. Newburg DS, Viscidi P, Ruff A, Yolken H. A human milk factor inhibits binding of HIV to the CD4 receptor. Pediatr Res 1992; 31: 22-28.
56. Van de Perre P, Simonon A, Hitimana DG et al. Infective and anti-infective properties of breast milk from HIV-infected women. Lancet 1993; 341: 914-918.
57. van der Berg H, Gerritsen EJ, van Tol MJ, Dooren LJ, Vossen JM. Ten years after acquiring an HIV-1 infection: a study in a cohort of eleven neonates infected by aliquots of a single plasma donation. Acta Paediatrica 1994; 83: 173-178.
58. Thomas PA, Weedon J, Krasinski K et al. Maternal predictors of perinatal HIV transmission. Pediatr Infect Dis 1994; 13: 489-494.
59. Kind C. Mother-to-child transmission of human immunodeficiency virus type 1: influence of parity and mode of delivery. Paediatric AIDS Group of Switzerland. Eur J Pediatr 1995; 154: 542-545.
60. Duliege AM, Amos CI, Felton S, Biggar RJ, Goedert JJ. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. J Pediatr 1995; 126: 625-632.
61. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection in first-born twins. Lancet 1991; 338: 1471-1475.
62. Kuhn L, Stein ZA, Thomas PA, Singh T, Tsai WY. Maternal-infant HIV transmission and circumstances of delivery. Am J Public Health 1994; 84: 1110-1115.
63. Anonymous. Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study. Lancet 1994; 343: 1464-1467.
64. Kuhn L, Bobat R, Coutsoudis A et al. Ceasarean deliveries and maternal-infant HIV transmission: results from a prospective study in South Africa. J Acq Imm Def Synd Human Retrovirol 1996; 11: 478-483.
65. Semprini AE, Castagna C, Ravizza M et al. The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 1995; 9: 913-917.
66. Scaravelli Thorne C, Newell ML. The management of pregnancy and delivery in HIV-infected women in Europe. Eur J Obstet Gynecol Rep Biol 1995; 62: 7-13.
67. Department of Health. Guidelines for Offering Voluntary Named HIV Antibody Testing to Women Receiving Antenatal Care. PL/CO(94)2. London: Welsh Office PSM(94). Department of Health, 1994.
68. Department of Health. Guidelines For Pre-Test Discussion on HIV Testing. London. Department of Health, 1996.
69. Davison CF, Holland FJ, Newell ML, Hudson CN, Peckham CS. Screening for HIV infection in pregnancy. AIDS Care 1993; 5: 135-140.
70. Anonymous. Strategies to reduce vertical transmission of HIV-1. CDR Weekly 1994; 4: 127-130.
71. Kumar RM, Hughes PF, Khurranna A. Zidovudine use in pregnancy: a report of 104 cases and the occurrence of birth defects. J Acq Immune Def Synd 1994; 7: 1034-1039.
72. Abrams EJ, Matheson PB, Thomas PA et al. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York Perinatal HIV Transmission Collaborative Study Group. Pediatrics 1995; 96: 451-458.
73. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New Engl J Med 1994; 331: 1173-1180.
74. Pillay D, Geddes AM. Antiviral drug resistance. Br Med y 1996; 313: 503-505.
75. Sandberg JA, Slikker W Jr. Developmental pharmacology and toxicology of anti-HIV therapeutic agents; dideoxynucleosides. FASEB Journal 1995; 9: 1157-1163.
76. Lewis P, Smith R. The management of HIV-positive pregnant women. Modern Midwife 1996; 6: 26-28.
77. Fuith LC, Czarnecki M, Wachter H, Fuchs D. Mode of delivery in HIV-1 infected women. Lancet 1992; 339: 1603.
78. Department of Health. Guidance for Clinical Health Care Workers: Protection Against Infection with HIV and Hepatitis Viruses. Recommendations of the Expert Advisory Group on AIDS. HMSO, London, 1990.
79. Ruff AJ. Breastmilk, breastfeeding, and transmission of viruses to the neonate. Sem Perinatol 1994; 18: 510-516.
80. Department of Health & Social Security. HIV Infection, Breastfeeding and Human Milk Banking in the United Kingdom. Letters from the Chief Medical Officer and the Chief Nursing Officer. London DHSS, 1989 (PL/CMO(89)4, PL/CNO(89)3).
81. Bradbeer CS. Mothers with HIV. Br med J 1989; 299: 806-807.
82. Ryder RW, Nsuami M, Nsa W et al. Mortality in HIV-1-seropositive women, their spouses and their newly born children during 36 months of follow-up in Kinshasa. AIDS 1994; 8: 667-672.
83. Falloon J, Eddy J, Wiener L, Pizzo PA. Human immunodeficiency virus infection in children. J Pediatr 1989; 114: 1-30.
84. Oxtoby MJ. Perinatally acquired human immunodeficiency virus infection. Pediatr Infect Dis J 1990; 9: 609-619.
85. Mayaux MJ, Burgard M, Teglas JP et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA 1996; 275: 606-610.
86. Frederick T, Mascola L, Eller A, O'Neil L, Byers B. Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Los Angeles County, University of South California Medical Center and the University of South California School of Medicine. Pediatr Infect Dis J 1994; 13: 1091-1097.
87. Rosenberg ZF, Fauci AS. Immunopathology and pathogenesis of human immunodeficiency virus infection. Pediatr Infect Dis 1991; 10: 230-238.
88. Forsyth BWC, Andiman WA, O'Connor T. Development of a prognosis-based clinical staging system for infants infected with human immunodeficiency virus. J Pediatr 1996; 129: 648-655.
89. Berger Albisetti M, Fanconi S et al. Pneumocystis carinii pneumonia in infants with vertically acquired HIV infection in Switzerland. Schweiz. Med Wochenschrift 1995; 125: 1162-1167.
90. Schupbach J, Tomasik Z, Jendis J et al. IgG, IgM, and IgA response to HIV in infants born to HIV-1 infected mothers. J Acq Immune Def Synd 1994; 7: 421-427.
91. Sison AV, Campos JM. Laboratory methods for early detection of HIV-1 in newborns and infants. Clin Microbiol Reviews 1992; 5: 238-247.
92. Klione MW, Lewis DE, Hollinger FB et al. A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J 1994; 13: 90-94.
93. Luzuriaga K, McQuilken P, Alimenti A, Somasundaran M, Hesselton RA, Sullivan JL. Early viremia and immune response in vertical human immunodeficiency virus type 1 infection. J Infect Dis 1993; 167: 1008-1013.
94. Weiblen BJ, Lee FL, Cooper ER et al. Early diagnoses of HIV infection in infants by detection of IgA HIV antibodies. Lancet 1990; 335: 988-990.
95. Gurtler L. Difficulties and strategies of HIV diagnosis. Lancet 1996; 348: 176-179.
96. Palumbo P. Laboratory findings in HIV infection in infancy. Clin Perinatol 1994; 12: 109-124.
97. Kovacs A, Xu J, Rasheed S et al. Comparison of a rapid nonisotopic polymerase chain reaction assay with four commonly used methods for the early diagnosis of human immunodeficiency virus type 1 infection in neonates and children. Pediatr Infect Dis J 1995; 14: 948-954.
98. Dunn DT, Brandt CD, Krivine et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995; 9: S7-S11.
99. Owens DK, Holodniy M, McDonald TW, Scott J, Sonnad S. A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants. JAMA 1996; 275: 1342-1348.
100. Miles SA, Balden E, Magpantay L et al. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. New Engl J Med 1993; 328: 297-302.
101. Quinn TC, Kline R, Moss MW, Livingston RA, Hutton N. Acid dissociation of immune complexes improves diagnostic utility of p24 antigen detection in perinatally acquired human immunodeficiency virus infection. J Infect Dis 1993; 167: 1193-1196.
102. Schupbach J, Boni J, Tomasik Z, Jendis J, Seger R, Kind C. Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis 1994; 170: 318-324.
103. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Pediatr Infect Dis J 1993; 12: 513-522.
104. Bryson YJ, Luzurgiaga K, Wara DW. Proposed definitions for in-utero versus intrapartum transmission of HIV-1. New Engl J Med 1992; 327: 1246-1247.
105. McKinney RE, Maha MA, Connor EM et al. Multicenter trial of oral zidovudine in children with advanced human immunodeficiency disease. New Engl J Med 1991; 324: 1018-1025.
106. Griffith BP, Booss J. Neurologic infections of the fetus and newborn. Neurol Clinics 1994; 12: 541-564.
107. Centers for Disease Control: Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR 1991; 40: 1-13.
108. Clumeck N. Antimicrobial prophylaxis in HIV-infected adults. J Antimicrob Chemother 1994; 33: 903-906.
109. Spector S, Gelber RD, McGrath N et al. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. New Engl J Med 1994; 331: 1181-1187.
110. 9/L or more: effect on viral, opportunistic, and bacterial infections. JAMA 1992; 268: 483-488.
111. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. New Engl J Med 1991; 325: 73-80.
112. Salisbury DM, Begg NT (Eds). 1996 Immunisation Against Infectious Disease. Edward Jenner Bicentenary Edition. London, HMSO 1996.
113. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43: 1-10.
114. Kind C, Brandle B, Wyler CA et al. Epidemiology of vertically-transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group. Eur J Pediatr 1992; 151: 442-448.
115. Mofenson LM, Burns DN. Passive immunization to prevent mother-infant transmission of human immunodeficiency virus: current issues and future directions. Pediatr Infect Dis J 1991; 10: 456-462.